Condition
Causalgia
Total Trials
6
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Terminated2
Unknown1
Enrolling By Invitation1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07170722Not ApplicableCompleted
Sub-threshold DRG Stimulation vs Sham in Established Responders
NCT06306157Phase 4Enrolling By Invitation
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
NCT03954080Not ApplicableCompleted
Trialing of ISS in Patients With CRPS
NCT02667717Not ApplicableTerminated
Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy
NCT01088256Phase 2TerminatedPrimary
Efficacy of Etoricoxib on Peripheral Hyperalgesia
NCT01523379UnknownPrimary
Efficacy of Parecoxib on Patients With CRPS
Showing all 6 trials